By the TutelaMedical.com Editorial Team | This article is for educational purposes only and does not constitute medical advice. These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before starting any new supplement, particularly if you take prescription medications. | Affiliate Disclosure: This article may contain affiliate links. If you purchase through them, TutelaMedical.com may earn a commission at no additional cost to you. This does not influence our editorial analysis.
What Memopryl Claims to Be
Memopryl is a daily nootropic capsule supplement distributed by MemoPryl Research and sold through ClickBank. According to the brand's published materials, it is formulated to support cognitive function, memory retention, mental clarity, and sustained concentration in adults. The product contains eight named ingredients: Ginkgo Biloba, Phosphatidylserine, Bacopa Monnieri Extract, N-Acetyl-L-Carnitine (ALCAR), St. John's Wort, L-Glutamine, Alpha-GPC, and Huperzine-A. The brand states manufacturing takes place in an FDA-registered, GMP-certified facility — this is a brand claim and has not been independently verified.
Before anything else, two facts should be on the table. First: no randomized, controlled clinical trial has tested the complete finished Memopryl formula. The eight individual ingredients each have peer-reviewed research records of varying quality and depth, but that research was conducted on those ingredients in isolation — not on the Memopryl blend as a whole. Second: the official Memopryl website does not publicly disclose per-ingredient milligram dosages. This means that while ingredient identity is confirmed, the specific dosages cannot be compared against the amounts used in published clinical research. Both of these points matter to anyone making an informed purchase decision, and neither gets stated clearly in most coverage of this product.
What follows is an ingredient-informed editorial evaluation based on verified source material and published research. It is not a clinical assessment of the Memopryl product.
The Cholinergic Triple-Pathway Design
The most structurally notable aspect of the Memopryl formula is not any single ingredient — it is the relationship between three of them. Alpha-GPC, N-Acetyl-L-Carnitine, and Huperzine-A all act on the brain's cholinergic system, which governs acetylcholine — the neurotransmitter most directly associated with memory formation, learning, and sustained attention. The three work through different mechanisms: Alpha-GPC delivers choline as a raw material for acetylcholine synthesis; ALCAR supports the neuronal energy metabolism and synthesis pathways that produce it; Huperzine-A inhibits acetylcholinesterase, the enzyme that breaks acetylcholine down, thereby extending its availability. The result is a formula designed to build acetylcholine from two directions while simultaneously slowing its degradation. This is a recognized multi-mechanism approach in the nootropic formulation category.
Whether this triple-pathway design is beneficial or creates overstimulation of the cholinergic system depends on individual neurochemistry and, critically, on whether the person is taking any prescription medications that also act on cholinergic pathways — particularly acetylcholinesterase inhibitors prescribed for cognitive conditions. For healthy adults not on such medications, the design is within the standard range for a multi-ingredient nootropic stack. For anyone on prescription cognitive medications, this design creates a clinically meaningful interaction concern that warrants a direct conversation with a physician before use. A full breakdown of Memopryl's interaction profile covers this in detail, including the separate St. John's Wort consideration.
The Eight Ingredients: What the Research Shows
The research context here applies to these ingredients as studied in isolation, not to the Memopryl formula as a product.
Ginkgo Biloba is one of the most-studied botanicals in cognitive health research, with proposed mechanisms around cerebral blood flow support and antioxidant protection. The evidence base is large and mixed. It performs most consistently in research on cognitive maintenance in older adults rather than enhancement in younger populations. The large GEM study found limited benefit for cognitive decline prevention in healthy older adults; other trials using standardized EGb 761 extract at adequate doses over extended periods showed more supportive outcomes for specific cognitive domains.
Phosphatidylserine is a phospholipid with one of the stronger research profiles in this category. The FDA has acknowledged a qualified health claim for Phosphatidylserine related to cognitive function and reduced dementia risk — with the explicit qualifier that the evidence is “limited and not conclusive.” That acknowledgment places it in a small group of supplement ingredients that have cleared even that qualified threshold with the FDA.
Bacopa Monnieri carries the most consistent human clinical research in the Memopryl formula. Multiple randomized, controlled trials and a 2014 meta-analysis in the Journal of Ethnopharmacology — examining 9 RCTs with 518 subjects — found that standardized Bacopa extract showed potential to improve cognition, particularly attentional speed. The critical caveat: Bacopa's research consistently points toward gradual, cumulative effects over at least 12 weeks of daily use. A two-week evaluation provides no meaningful data on this ingredient's contribution.
N-Acetyl-L-Carnitine (ALCAR) crosses the blood-brain barrier more effectively than standard carnitine. Its primary research focus is brain energy metabolism — facilitating fatty acid transport into neuronal mitochondria. The cognitive complaint most aligned with ALCAR's mechanism is mental fatigue and sustained concentration difficulty rather than acute memory failures.
St. John's Wort is investigated for mood and emotional well-being through interactions with serotonin and dopamine pathways. Its inclusion in a nootropic formula reflects the documented relationship between emotional state and cognitive performance. It also carries the most significant safety consideration in the formula: St. John's Wort is a well-documented inducer of CYP3A4 and CYP2C9 cytochrome P450 enzymes. This metabolic pathway processes a wide range of prescription medications. Combinations with SSRIs and MAOIs can cause serotonin syndrome. It can reduce the effectiveness of oral contraceptives, blood thinners, immunosuppressants, certain HIV medications, anticonvulsants, and some cardiac medications. The National Center for Complementary and Integrative Health (NCCIH) specifically identifies St. John's Wort as one of the most clinically significant herb-drug interaction risks in common use. This is a medical safety point. If you take any prescription medication, discuss this ingredient with your physician before using Memopryl.
L-Glutamine is a precursor for both glutamate and GABA — the brain's primary excitatory and inhibitory neurotransmitters. Research has explored its role in brain energy homeostasis and maintaining neurochemical balance during sustained cognitive demand.
Alpha-GPC is among the most bioavailable choline sources in supplement form. Choline is converted into acetylcholine in the brain; Alpha-GPC's ability to cross the blood-brain barrier efficiently makes it one of the more mechanistically direct ingredients in the cholinergic support category.
Huperzine-A is a natural alkaloid from firmoss (Huperzia serrata) that acts as an acetylcholinesterase inhibitor — the same general mechanism as prescription cognitive medications, though with different pharmacokinetics and regulatory status. Its pairing with Alpha-GPC creates the dual-direction cholinergic support described above. Read the complete Memopryl ingredient analysis for dose-context research on each compound.
The Dosage Transparency Problem
This is the most practically important limitation for a prospective buyer. Per-ingredient milligram dosages are not publicly disclosed on the Memopryl website. This means there is no way to externally verify whether the Bacopa Monnieri in the formula falls within the 300–450 mg range used in the trials that produced the strongest outcomes, whether the Ginkgo is standardized to the flavone glycoside percentages associated with EGb 761 research, or whether the Huperzine-A is dosed conservatively enough to avoid the headache and GI disruption that occurs at higher amounts. Ingredient identity is confirmed. Efficacy assessment requires dosage transparency that the brand has not provided. For comparison: premium nootropic products sold outside the ClickBank ecosystem — Mind Lab Pro, for example — list specific per-ingredient dosages on their product pages, allowing that comparison to be made before purchase.
Pricing and Refund Policy
Memopryl is available in three purchase tiers. A 2-bottle supply (60-day) is priced at $79 per bottle, totaling $158 plus $9.99 shipping. A 3-bottle supply (90-day) is $69 per bottle, $207 total with free shipping. A 6-bottle supply (180-day) is $49 per bottle, $294 total with free shipping. Given that Bacopa-based formulas require a minimum of 12 weeks for a fair evaluation, the 3-bottle option aligns most directly with the research timeline.
The refund policy is a 60-day money-back guarantee from the date of shipping. The return requires all bottles — including empty bottles — to be sent back. The buyer pays return shipping. Refunds process through ClickBank and typically take 5 to 10 business days after the return is received. A partial refund may result if not all bottles are returned. The return address on record is 19655 E 35th Drive, Suite 100, Aurora, CO 80011.
Who Is Memopryl For — And Who Should Not Use It
Memopryl is designed for healthy adults seeking proactive cognitive support — adults in midlife experiencing the gradual cognitive changes associated with aging, professionals managing sustained concentration demands, or anyone interested in a multi-mechanism nootropic stack. It is not appropriate for individuals under 18, pregnant or nursing women, or people with diagnosed health conditions without prior medical clearance.
The list of people who should not use Memopryl without physician guidance is specific and non-negotiable. Anyone taking SSRIs, MAOIs, or any antidepressant medication. Anyone on blood thinners including warfarin or aspirin therapy. Anyone taking oral contraceptives. Anyone on immunosuppressants, anticonvulsants, protease inhibitors, or cardiac medications. Anyone on prescription acetylcholinesterase inhibitors for cognitive conditions. This is not a formality. The St. John's Wort in this formula has clinically documented interactions with all of these medication categories, and the triple-cholinergic design creates a separate consideration for the last group. See the Memopryl safety and drug interaction guide for the complete profile.
Should You Try Memopryl?
For healthy adults not on prescription medications, Memopryl's ingredient selection is reasonable. Bacopa, Phosphatidylserine, and the Alpha-GPC/Huperzine-A pairing are among the more research-supported components in the nootropic category. The cholinergic triple-pathway design is mechanistically coherent. These are meaningful differentiators from formulas built around less-studied compounds.
The honest limitations are the dosage transparency gap and the absence of a finished-product clinical trial. These are not unique to Memopryl — they apply to most products in this category. What is specific to Memopryl is the St. John's Wort inclusion, which raises the medication interaction bar higher than most competing formulas. That distinction matters most to the buyer evaluating this product while also managing other aspects of their health.
Setting realistic expectations is the most useful thing a review can offer: effects from a Bacopa-containing formula build gradually over 8 to 12 weeks of consistent use. A two-week trial produces no meaningful data. The 60-day money-back window aligns roughly with the minimum useful evaluation timeline for this formula.
For a detailed breakdown of what distinguishes Memopryl's formula from closely competing products on the market, read the Memopryl vs. other nootropics comparison. The complete ingredient breakdown covers the research context for each compound in further depth. TutelaMedical.com's independent nootropic rankings provide broader context for where Memopryl sits in the current market.
Frequently Asked Questions
Does Memopryl work?
No clinical trial has tested the finished Memopryl formula. Individual ingredients including Bacopa Monnieri and Phosphatidylserine have peer-reviewed research records, but that research applies to those ingredients in isolation — not to the Memopryl blend as a complete product. Realistic expectations mean a minimum 60-day evaluation window for Bacopa-containing formulas.
Is Memopryl safe to take?
For healthy adults not on prescription medications, the ingredient list raises no immediate red flags. However, St. John's Wort — one of Memopryl's eight ingredients — has well-documented interactions with numerous prescription medications. Anyone on prescription medication must consult a physician before using Memopryl.
What is the Memopryl refund policy?
Memopryl is backed by a 60-day money-back guarantee from the date of shipping. The buyer must return all bottles — including empty bottles — and pays return shipping. Refunds typically process within 5 to 10 business days of the return being received. ClickBank is the authorized retailer.
Where is Memopryl sold?
Memopryl is sold exclusively through its official website at memopryl.com, with ClickBank as the authorized payment processor. It is not available on Amazon or in retail stores.